Summit Therapeutics PLC (FRA:UVF1)
€ 0.2 0 (0%) Market Cap: 65.72 Mil Enterprise Value: -366.07 Mil PE Ratio: 0 PB Ratio: 31.60 GF Score: 14/100

Q1 2024 Summit Therapeutics Inc Earnings Call Transcript

May 01, 2024 / 01:00PM GMT
Operator

Good morning, ladies and gentlemen, and thank you for standing by. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Summit Therapeutics First Quarter 2024 earnings conference call. (Operator Instructions)

We do not expect any technical difficulties today. However, in the event that we lose the webcast connection and are unable to provide any updates, please wait up to 10 minutes for resolution. Please refer to the Company's website for updates. Also, please note that today's call is being recorded. Thank you and I would now like to turn the conference over to Mr. Dave GaN, cars, Chief Business and Strategy Officer. You may begin.

Dave Gancarz
Summit Therapeutics Inc - Chief Business, Strategy Officer

Thank you.

Good morning, and thank you for joining us. Our press release was issued this morning and is available on the homepage of our website. Our Form 10 Q was also filed earlier this morning and is available on our website. Today's call is being simultaneously webcast and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot